308 related articles for article (PubMed ID: 14685876)
1. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.
Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Stein H
Graefes Arch Clin Exp Ophthalmol; 2004 Feb; 242(2):130-145. PubMed ID: 14685876
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.
Coupland SE; Krause L; Delecluse HJ; Anagnostopoulos I; Foss HD; Hummel M; Bornfeld N; Lee WR; Stein H
Ophthalmology; 1998 Aug; 105(8):1430-41. PubMed ID: 9709754
[TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
4. Ocular adnexal lymphoproliferative disease: a series of 73 cases.
McKelvie PA; McNab A; Francis IC; Fox R; O'Day J
Clin Exp Ophthalmol; 2001 Dec; 29(6):387-93. PubMed ID: 11778809
[TBL] [Abstract][Full Text] [Related]
5. Ocular adnexal lymphomas: five case presentations and a review of the literature.
Coupland SE; Hummel M; Stein H
Surv Ophthalmol; 2002; 47(5):470-90. PubMed ID: 12431695
[TBL] [Abstract][Full Text] [Related]
6. Unifocal and multifocal reactive lymphoid hyperplasia vs follicular lymphoma of the ocular adnexa.
Stacy RC; Jakobiec FA; Schoenfield L; Singh AD
Am J Ophthalmol; 2010 Sep; 150(3):412-426.e1. PubMed ID: 20599186
[TBL] [Abstract][Full Text] [Related]
7. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma.
Hatef E; Roberts D; McLaughlin P; Pro B; Esmaeli B
Arch Ophthalmol; 2007 Dec; 125(12):1663-7. PubMed ID: 18071119
[TBL] [Abstract][Full Text] [Related]
9. Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study.
Vest SD; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Hindso TG; Holm F; Honavar SG; Khong JJ; Kirkegaard MK; McKelvie PA; Mikkelsen LH; Mulay K; Rasmussen PK; Siersma V; Sjö LD; Sniegowski MC; Thuro BA; Vemuganti GK; Heegaard S
Br J Ophthalmol; 2023 Sep; 107(9):1231-1238. PubMed ID: 35512851
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative diseases of the ocular adnexa in Korea.
Oh DE; Kim YD
Arch Ophthalmol; 2007 Dec; 125(12):1668-73. PubMed ID: 18071120
[TBL] [Abstract][Full Text] [Related]
11. Ocular adnexal follicular lymphoma: a multicenter international study.
Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification.
Kwon M; Lee JS; Lee C; Yoon DH; Sa HS
Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417
[TBL] [Abstract][Full Text] [Related]
13. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
Coupland SE
Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Assessment of Ocular Adnexal Lymphoproliferative Lesions at a Tertiary Eye Hospital in Iran.
Asadi-Amoli F; Nozarian Z; Bonaki HN; Mehrtash V; Entezari S
Asian Pac J Cancer Prev; 2016; 17(8):3727-31. PubMed ID: 27644607
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma of the ocular adnexa: A study of 353 cases.
Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
[TBL] [Abstract][Full Text] [Related]
17. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.
Auw-Haedrich C; Coupland SE; Kapp A; Schmitt-Gräff A; Buchen R; Witschel H
Br J Ophthalmol; 2001 Jan; 85(1):63-9. PubMed ID: 11133714
[TBL] [Abstract][Full Text] [Related]
18. BCL10 expression in ocular adnexal lymphomas.
Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic findings and frequency of clonality detected by the polymerase chain reaction in ocular adnexal lymphoproliferative lesions.
White VA; Gascoyne RD; McNeil BK; Chang WY; Brewer LV; Rootman J
Mod Pathol; 1996 Nov; 9(11):1052-61. PubMed ID: 8933515
[TBL] [Abstract][Full Text] [Related]
20. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
